Literature DB >> 21923229

Pharmacological treatments for personality disorders.

Joel Paris1.   

Abstract

Abstract This paper presents a systematic review of clinical trials of drugs for patients with personality disorders. Almost all trials have concerned the treatment of borderline personality disorder (BPD). Research yields some evidence for symptomatic improvement with antidepressants, mood stabilizers, and antipsychotics. However, drug treatment does not produce remission of BPD. Routine prescription of these agents for these patients is not evidence-based.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21923229     DOI： 10.3109/09540261.2011.586993

Source DB:  PubMed          Journal:  Int Rev Psychiatry        ISSN： 0954-0261


  4 in total

1.  Effectiveness and tolerability of long-acting intramuscular risperidone as adjuvant treatment in refractory borderline personality disorder.

Authors:  J L Carrasco; N Palomares; M Díaz Marsá
Journal:  Psychopharmacology (Berl)       Date:  2012-10-11       Impact factor: 4.530

2.  The Epidemiology of Antisocial Behavioral Syndromes in Adulthood: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III.

Authors:  Risë B Goldstein; S Patricia Chou; Tulshi D Saha; Sharon M Smith; Jeesun Jung; Haitao Zhang; Roger P Pickering; W June Ruan; Boji Huang; Bridget F Grant
Journal:  J Clin Psychiatry       Date:  2017-01       Impact factor: 4.384

Review 3.  A Computational Account of Borderline Personality Disorder: Impaired Predictive Learning about Self and Others Through Bodily Simulation.

Authors:  Sarah K Fineberg; Matthew Steinfeld; Judson A Brewer; Philip R Corlett
Journal:  Front Psychiatry       Date:  2014-08-27       Impact factor: 4.157

4.  Second-generation antipsychotic use in borderline personality disorder: What are we targeting?

Authors:  Adrian Wasylyshen; Andrew M Williams
Journal:  Ment Health Clin       Date:  2016-03-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.